<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00631553</url>
  </required_header>
  <id_info>
    <org_study_id>12014</org_study_id>
    <nct_id>NCT00631553</nct_id>
  </id_info>
  <brief_title>Assessment of Changes in Renal Cortical and Medullary Blood Flow by Contrast Ultrasound</brief_title>
  <official_title>Assessment of Changes in Renal Cortical and Medullary Blood Flow by Contrast Ultrasound</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Virginia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institutes of Health (NIH)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Virginia</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine if contrast enhanced ultrasound (CEU) using
      microbubbles, is useful in assessing changes in kidney blood flow.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>June 2006</start_date>
  <completion_date type="Anticipated">December 2009</completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Kidney</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>perflutren lipid microspheres</intervention_name>
    <description>1.3 ml in 30 ml of saline, infused into vein at 2ml / min and titrated for optimal image quality (not to exceed 10 ml/ min at any time).</description>
    <other_name>Definity</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy adults

          -  Males and females

          -  Ages 18-65 years old

        Exclusion Criteria:

          -  Pregnancy or lactation

          -  H/o kidney disease

          -  H/o congestive heart failure, ischemic heart disease, severe pulmonary disease or
             allergy to the drug

          -  H/o any cardiovascular disease

          -  Abnormal liver function (liver function tests out of specified ranges)

          -  Screening urinalysis which indicates infection or inflammation

          -  Taking regular medications (except for over-the-counter vitamins or hormonal
             contraceptives.)

          -  Taking supplements, like protein shakes

          -  Unwilling or unable to eat chicken (used as protein meal)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kambiz Kalantarinia, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Virginia</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Kambiz Kalantarinia, MD</last_name>
    <phone>434 924 5125</phone>
    <email>kk6c@virginia.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Lori Ratliff, RN ANP</last_name>
    <phone>434 924 5820</phone>
    <phone_ext>4-1572</phone_ext>
    <email>lbr@virginia.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of Virginia Health System</name>
      <address>
        <city>Charlottesville</city>
        <state>Virginia</state>
        <zip>22908</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kalantarinia</last_name>
      <email>kk6cQ@virginia.edu</email>
    </contact>
    <contact_backup>
      <last_name>Ratliff</last_name>
      <email>lbr@virgina.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Kambiz Kalantarinia, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 27, 2008</study_first_submitted>
  <study_first_submitted_qc>March 6, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 7, 2008</study_first_posted>
  <last_update_submitted>August 6, 2008</last_update_submitted>
  <last_update_submitted_qc>August 6, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 7, 2008</last_update_posted>
  <responsible_party>
    <name_title>Kambiz Kalantarinia MD Assitant Professor of Medicine</name_title>
    <organization>University of Virginia Dept of Medicine</organization>
  </responsible_party>
  <pending_results>
    <submitted>March 19, 2009</submitted>
    <returned>May 1, 2009</returned>
    <submitted>April 25, 2011</submitted>
    <submission_canceled>Unknown</submission_canceled>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

